Company filings profile · CIK 0001962011

Kairos Pharma, LTD. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Kairos Pharma, LTD. (KAPA): 6 filings in the last 90 days vs 8 in the prior 90 (filing-velocity cooling ↓ · 0.75×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 7, 2026. Source-linked, daily-refreshed.

Material 8-K events — Kairos Pharma, LTD.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 6, 2026Other Events; Financial Statements and Exhibits↗
Sep 14, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 21, 2026Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits↗
Jul 22, 2026Entry into a Material Agreement; Other Events; Financial Statements and Exhibits↗
Jul 15, 2026Other Events; Financial Statements and Exhibits↗
Jun 30, 2026Item 5.07↗
Jun 4, 2026Other Events; Financial Statements and Exhibits↗
May 18, 2026Other Events; Financial Statements and Exhibits↗
Mar 2, 2026Entry into a Material Agreement; Other Events; Financial Statements and Exhibits↗
Feb 26, 2026Other Events; Financial Statements and Exhibits↗
Oct 15, 2025Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
Oct 7, 2025Entry into a Material Agreement; Other Events; Financial Statements and Exhibits↗
Sep 18, 2025Other Events; Financial Statements and Exhibits↗
Sep 11, 2025Other Events; Financial Statements and Exhibits↗
Sep 3, 2025Other Events; Financial Statements and Exhibits↗

Watch Kairos Pharma, LTD. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Dec 30, 20254↗
Dec 23, 20254↗
Nov 26, 20254↗
Nov 26, 20254↗
Nov 26, 20254↗
Nov 26, 20254↗
Nov 26, 20254↗
Apr 30, 20253↗
Apr 7, 20254↗

Recent filings

FiledFormDetail
Oct 6, 20268-K Other Events; Financial Statements and Exhibits ↗
Sep 14, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 21, 20268-K Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 12, 202610-Q 10-Q ↗
Jul 22, 20268-K Entry into a Material Agreement; Other Events; Financial Statements and Exhibits ↗
Jul 15, 20268-K Other Events; Financial Statements and Exhibits ↗
Jun 30, 20268-K Item 5.07 ↗
Jun 4, 20268-K Other Events; Financial Statements and Exhibits ↗
May 26, 2026DEFA14A DEFA14A ↗
May 22, 2026ARS ARS ↗
May 22, 2026DEF 14A DEF 14A ↗
May 18, 20268-K Other Events; Financial Statements and Exhibits ↗
May 13, 202610-Q 10-Q ↗
May 11, 2026PRE 14A PRE 14A ↗
Apr 1, 2026424B3 424B3 ↗
Apr 1, 2026424B3 424B3 ↗
Mar 31, 202610-K 10-K ↗
Mar 2, 20268-K Entry into a Material Agreement; Other Events; Financial Statements and Exhibits ↗
Feb 26, 20268-K Other Events; Financial Statements and Exhibits ↗
Jan 23, 2026EFFECT Item ; Item ; Item ↗
Jan 21, 2026CORRESP ↗
Jan 15, 2026UPLOAD ↗
Jan 13, 2026S-3 S-3 ↗
Dec 30, 20254 4 ↗
Dec 23, 20254 4 ↗
Nov 26, 20254 4 ↗
Nov 26, 20254 4 ↗
Nov 26, 20254 4 ↗
Nov 26, 20254 4 ↗
Nov 26, 20254 4 ↗
Nov 14, 202510-Q 10-Q ↗
Oct 15, 20258-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Oct 7, 20258-K Entry into a Material Agreement; Other Events; Financial Statements and Exhibits ↗
Sep 18, 20258-K Other Events; Financial Statements and Exhibits ↗
Sep 11, 20258-K Other Events; Financial Statements and Exhibits ↗
Sep 3, 20258-K Other Events; Financial Statements and Exhibits ↗
Aug 19, 2025424B3 424B3 ↗
Aug 14, 2025SCHEDULE 13G/A ↗
Aug 12, 202510-Q 10-Q ↗
Jul 28, 202510-K/A 10-K/A ↗